Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
1101
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $12.4M | 0.02% |
847,945
+95,719
| +13% | +$1.42M |
|
|
SPLK
1102
DELISTED
Splunk Inc
SPLK
| $12.3M | 0.02% |
+198,200
| New | +$11.9M |
|
1103
Hawaiian Electric Industries
HE
$2.06B
| $12.3M | 0.02% |
370,300
-140,000
| -27% | -$4.65M |
|
1104
MGE Energy Inc
MGEE
$3.07B
| $12.3M | 0.02% |
189,750
+41,200
| +28% | +$2.61M |
|
|
CSR
1105
Centerspace
CSR
$925M
| $12.3M | 0.02% |
207,810
-5,630
| -3% | -$362K |
|
|
BELFB
1106
Bel Fuse Inc Class B
BELFB
$4.25B
| $12.3M | 0.02% |
479,717
+75,700
| +19% | +$2.16M |
|
1107
Stewart Information Services
STC
$2B
| $12.2M | 0.02% |
276,800
-92,900
| -25% | -$4.09M |
|
|
PCBK
1108
DELISTED
Pacific Continental Corp
PCBK
| $12.2M | 0.02% |
499,156
+55,706
| +13% | +$1.38M |
|
|
SCMP
1109
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $12.2M | 0.02% |
1,111,400
-348,400
| -24% | -$4.04M |
|
1110
Mitsubishi UFJ Financial
MUFG
$257B
| $12.2M | 0.02% |
1,927,900
-861,800
| -31% | -$5.64M |
|
1111
First Busey Corp
BUSE
$2.58B
| $12.2M | 0.02% |
414,900
+53,300
| +15% | +$1.61M |
|
1112
Entravision Communication
EVC
$832M
| $12.2M | 0.02% |
1,965,552
+47,700
| +2% | +$277K |
|
|
CBPX
1113
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $12.2M | 0.02% |
496,700
+375,000
| +308% | +$9.04M |
|
|
EVRI
1114
DELISTED
Everi Holdings
EVRI
| $12.2M | 0.02% |
2,537,378
+1,094,078
| +76% | +$3.57M |
|
1115
LivePerson
LPSN
$34.1M
| $12.1M | 0.02% |
117,987
+3,447
| +3% | +$368K |
|
1116
CRA International
CRAI
$1.06B
| $12.1M | 0.02% |
342,831
+17,100
| +5% | +$599K |
|
|
UCTT
1117
Ultra Clean Holdings
UCTT
$4.1B
| $12.1M | 0.02% |
716,700
-46,800
| -6% | -$621K |
|
1118
Capri Holdings
CPRI
$1.77B
| $12.1M | 0.02% |
+317,200
| New | +$12.5M |
|
1119
Acadia Healthcare
ACHC
$2.95B
| $12M | 0.02% |
275,200
-695,300
| -72% | -$28.2M |
|
1120
Enova International
ENVA
$6.48B
| $12M | 0.02% |
806,800
-97,400
| -11% | -$1.38M |
|
1121
Nice
NICE
$5.78B
| $12M | 0.02% |
175,944
+134,800
| +328% | +$9.25M |
|
1122
CGI
GIB
$15.3B
| $11.9M | 0.02% |
248,800
+205,200
| +471% | +$9.85M |
|
1123
Enterprise Financial Services Corp
EFSC
$2.41B
| $11.9M | 0.02% |
280,900
+76,100
| +37% | +$3.23M |
|
|
JOYY
1124
JOYY Inc
JOYY
$3.74B
| $11.9M | 0.02% |
258,292
-245,410
| -49% | -$10.9M |
|
|
SIGM
1125
DELISTED
Sigma Designs Inc
SIGM
| $11.8M | 0.02% |
1,893,200
+120,100
| +7% | +$740K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.